Neuroprotective effects of swimming training in a mouse model of Parkinson's disease induced by 6-hydroxydopamine

Neuroscience

Volumn 256, Issue , 2014, Pages 61-71

  Goes, A T R ^a   Souza, L C ^a   Filho, C B ^a   Del Fabbro, L ^a   De Gomes, M G ^a   Boeira, S P ^a   Jesse, C R ^a  

^a UNIVERSIDADE FEDERAL DO PAMPA   (Brazil)

Author keywords

6 hydroxydopamine; Cognitive impairment; Exercise; Neuroinflammation; Oxidative stress; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HOMOVANILLIC ACID; INTERLEUKIN 1BETA; OXIDOPAMINE; REACTIVE OXYGEN METABOLITE; CATALASE; CITRATE SYNTHASE; DOPAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL EFFECTIVENESS; COGNITIVE DEFECT; CORPUS STRIATUM; DEGENERATIVE DISEASE; DEPRESSION; DISEASE MODEL; ENZYME ACTIVITY; EXERCISE; FALLING; LONG TERM MEMORY; MALE; MEMORY DISORDER; MOLECULAR MECHANICS; MOTOR DYSFUNCTION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; ROTAROD TEST; SWIMMING; ANIMAL; C57BL MOUSE; DRUG EFFECTS; ENZYMOLOGY; EXPLORATORY BEHAVIOR; IMMOBILIZATION; KINESIOTHERAPY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOMOTOR PERFORMANCE; RECOGNITION; SKELETAL MUSCLE;

ANIMALS; CATALASE; CITRATE (SI)-SYNTHASE; CORPUS STRIATUM; DEPRESSION; DISEASE MODELS, ANIMAL; EXERCISE THERAPY; EXPLORATORY BEHAVIOR; GLUTATHIONE PEROXIDASE; HINDLIMB SUSPENSION; HYDROXYDOPAMINES; MALE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; RECOGNITION (PSYCHOLOGY); ROTAROD PERFORMANCE TEST; SWIMMING;

EID: 84887517269     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.09.042     Document Type: Article

References (64)

1. Aebi H. Catalase in vitro. Methods Enzymol 1984, 105:121-126.
2. Aksu I., Topcu A., Camsari U.M., Acikgoz O. Effect of acute and chronic exercise on oxidant-antioxidant equilibrium in rat hippocampus, prefrontal cortex and striatum. Neurosci Lett 2009, 452:281-285.
3. Almeida W.S., Lima L.C., Cunha V.N., Cunha R.R., Araújo R.C., Barros C.C., Simões H.G., Campbell C.S. Assessment of aerobic capacity during swimming exercise in ob/ob mice. Cell Biochem Funct 2011, 29:666-672.
4. Andrew R., Watson D.G., Best S.A., Midgley J.M., Wenlong H., Petty R.K. The determination of hydroxydopamine and other trace amines in the urine of parkinsonian patients and normal control. Neurochem Res 1993, 18:1175-1177.
5. Ayán C., Cancela J. Feasibility of 2 different water-based exercise training programs in patients with Parkinson's disease: a pilot study. Arch Phys Med Rehabil 2012, 93:1709-1714.
6. Barnum C.J., Tansey M.G. Modeling neuroinflammatory pathogenesis of Parkinson's disease. Prog Brain Res 2010, 184:113-132.
7. Bloomer R.J., Goldfarb A.H. Anaerobic exercise and oxidative stress: a review. Can J Appl Physiol 2004, 29:245-263.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Anal Biochem 1976, 72:248-254.
9. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol 1985, 113:484-490.
10. Carlsson T., Schindler F.R., Höllerhage M., Depboylu C., Arias-Carrión O., Schnurrbusch S., Rösler T.W., Wozny W., Schwall G.P., Groebe K., Oertel W.H., Brundin P., Schrattenholz A., Höglinger G.U. Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neurochem 2011, 117:1066-1074.
11. Cavagnolli D.A., Esteves A.M., Castiglione M.L., Batista I.R., Bressan R.A., Tufik S., De Mello M.T. Dopamine transporter shown by SPECT in patients with periodic leg movement after acute physical exercise. Med Sci Sports Exerc 2013, 45:224-229.
12. Contarteze R.V.L., Manchado F.D.B., Gobatto C.A., De Mello M.A.R. Stress biomarkers in rats submitted to swimming and treadmill running exercises. Comp Biochem Physiol A Mol Integr Physiol 2008, 151:415-422.
13. Costa C., Sgobio C., Siliquini S., Tozzi A., Tantucci M., Ghiglieri V., Di Filippo M., Pendolino V., de Iure A., Marti M., Morari M., Spillantini M.G., Latagliata E.C., Pascucci T., Puglisi-Allegra S., Gardoni F., Di Luca M., Picconi B., Calabresi P. Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease. Brain 2012, 135:1884-1899.
14. Cryan J.F., Mombereau C., Vassout A. The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 2005, 29:571-625.
15. Dasuri K., Zhang L., Keller J.N. Oxidative stress, neurodegeneration, and the balance of protein degradation and protein synthesis. Free Radic Biol Med 2013, 62:170-185.
16. De Leonibus E., Managò F., Giordani F., Petrosino F., Lopez S., Oliverio A., Amalric M., Mele A. Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacology 2009, 34:729-738.
17. De Leonibus E., Pascucci T., Lopez S., Oliverio A., Amalric M., Mele A. Spatial deficits in a mouse model of Parkinson disease. Psychopharmacology 2007, 194:517-525.
18. De Moor M.H., Beem A.L., Stubbe J.H., Boomsma D.I., De Geus E.J. Regular exercise, anxiety, depression and personality: a population-based study. Prev Med 2006, 42:273-279.
19. Dimatelis J.J., Hendricks S., Hsieh J.H., Vlok M.N., Bugarith K., Daniels W.M., Russell V.A. Exercise partially reverses the effect of maternal separation on hippocampal proteins in 6-hydroxydopamine lesioned rat brain. Exp Physiol 2013, 98:233-244.
20. Duman C.H., Schlesinger L., Russell D.S., Duman R.S. Voluntary exercise produces antidepressant and anxiolytic behavioral effects in mice. Brain Res 2008, 1199:148-158.
21. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 1957, 46:209.
22. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. Behav Brain Res 1988, 31:47-59.
23. Ferraz A.C., Matheussi F., Szawka R.E., Rizelio V., Delattre A.M., Rigon P., Hermel E.E.S., Xavier L.L., Achaval M., Alselmo-Franci J.A. Evaluation of estrogen neuroprotective effect on nigrostraital dopaminergic neurons following 6-OHDA injection into the substantia nigra pars compacta or medial forebrain bundle. Neurochem Res 2008, 33:1238-1246.
24. Fisher B.E., Petzinger G.M., Nixon K., Hogg E., Bremmer S., Meshul C.K. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia. J Neurosci Res 2004, 77:378-390.
25. Gobatto C.A., De Mello M.A., Sibuya C.Y., De Azevedo J.R., Dos Santos L.A., Kokubun E. Maximal lactate steady state in rats submitted to swimming exercise. Comp Biochem Physiol A Mol Integr Physiol 2001, 130:21-27.
26. Godoy M.C., Fighera M.R., Souza F.R., Flores A.E., Rubin M.A., Oliveira M.R., Zanatta N., Martins M.A., Bonacorso H.G., Mello C.F. Alpha 2-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone. Eur J Pharmacol 2004, 496:93-97.
27. Habig W.H., Jakoby W.B. Glutathione S-transferases (rat and humam). Methods Enzymol 1981, 77:218-231.
28. Haobam R., Sindhu K.M., Chandra G., Mohanakumar K.P. Swim-test as a function of motor impairment in MPTP model of Parkinson's disease: a comparative study in two mouse strains. Behav Brain Res 2005, 8:159-167.
29. Hirsch E.C., Vyas S., Hunot S. Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord 2012, 18:210-212.
30. Hopkins M.E., Bucci D.J. BDNF expression in perirhinal cortex is associated with exercise-induced improvement in object recognition memory. Neurobiol Learn Mem 2010, 94:278-284.
31. Huang T.H., Hsieh S.S., Liu S.H., Chang F.L., Lin S.C., Yang R.S. Swimming training increases the post-yield energy of bone in young male rats. Calcif Tissue Int 2010, 86:142-153.
32. Iancu R., Mohapel P., Brundin P., Paul G. Behavioral characterization of unilateral 6-OHDA lesion model of Parkinson's disease in mice. Behav Brain Res 2005, 162:1-10.
33. Ji L.L., Gomez-Cabrera M.C., Vina J. Exercise and hormesis activation of cellular antioxidant signaling pathway. Ann N Y Acad Sci 2006, 1067:425-435.
34. Kabuto H., Yamanushi T.T. Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model. Neurochem Res 2011, 36:2244-2249.
35. Kim D.S., Palmiter R.D. Interaction of dopamine and adenosine receptor function in behavior: studies with dopamine-deficient mice. Front Biosci 2008, 13:2311-2318.
36. Koprich J.B., Reske-Nielsen C., Mithal P., Isacson O. Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J Neuroinflamm 2008, 5:8.
37. Kramer J.H., Nelson A., Johnson J.K., Yaffe K., Glenn S., Rosen H.J., Miller B.L. Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 2006, 22:306-311.
38. Leek B.T., Mudaliar S.R., Henry R., Mathieu-Costello O., Richardson R.S. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol 2001, 280:441-447.
39. Loetchutinat C., Kothan S., Dechsupa S., Meesungnoen J., Jay-Gerin J., Mankhetkorn S. Spectrofluorometric determination of intracellular levels of reactive oxygen species in drug-sensitive and drug-resistant cancer cells using the 2',7'-dichlorofluorescein diacetate assay. Rad Phys Chem 2005, 72:323-331.
40. Mabandla M.V., Russell V.A. Voluntary exercise reduces the neurotoxic effects of 6-hydroxydopamine in maternally separated rats. Behav Brain Res 2010, 211:16-22.
41. Magen I., Fleming S.M., Zhu C., Garcia E.C., Cardiff K.M., Dinh D., De La Rosa K., Sanchez M., Torres E.R., Masliah E., Jentsch J.D., Chesselet M.F. Cognitive deficits in a mouse model of pre-manifest Parkinson's disease. Eur J Neurosci 2012, 35:870-882.
42. Mann P.B., Jiang W., Zhu Z., Wolfe P., McTiernan A., Thompson H.J. Wheel running, skeletal muscle aerobic capacity and 1-methyl-1-nitrosourea induced mammary carcinogenesis in the rat. Carcinogenesis 2010, 31:1279-1283.
43. Moore D.J., West A.B., Dawson V.L. Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 2005, 28:57-87.
44. Nilsson F.M., Kessing L.V., Bolwig T.G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001, 104:380-386.
45. Noyce A.J., Bestwick J.P., Silveira-Moriyama L., Hawkes C.H., Giovannoni G., Lees A.J., Schrag A. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 2012, 72:893-901.
46. O'Dell S.J., Galvez B.A., Ball A.J., Marshall J.F. Running wheel exercise ameliorates methamphetamine-induced damage to dopamine and serotonin terminals. Synapse 2012, 66:71-80.
47. Opacka-Juffry J., Wilson A.W., Blunt S.B. Effects of pergolide treatment on in vivo hydroxyl free radical formation during infusion of 6-hydroxydopamine in rat striatum. Brain Res 1998, 810:27-33.
48. Petzinger G.M., Walsh J.P., Akopian G., Hogg E., Abernathy A., Arevalo P. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl- 4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci 2007, 27:5291-5300.
49. Phani S., Loike J.D., Przedborski S. Neurodegeneration and inflammation in Parkinson's disease. Parkinsonism Relat Disord 2012, 18:207-209.
50. Pollak D.D., Rey C.E., Monje F.J. Rodent models in depression research: classical strategies and new directions. Ann Med 2010, 42:252-264.
51. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
52. Santiago R.M., Barbieiro J., Lima M.M., Dombrowski P.A., Andreatini R., Vital M.A. Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry 2010, 34:1104-1114.
53. Schallert T., Fleming S.M., Leasure J.L., Tillerson J.L., Bland S.T. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology 2000, 39:777-787.
54. Schrag A. Psychiatric aspects of Parkinson's disease - an update. J Neurol 2004, 251:795-804.
55. Shobana C., Kumar R.R., Sumathi T. Alcoholic extract of Bacopa monniera Linn. protects against 6-hydroxydopamine-induced changes in behavioral and biochemical aspects: a pilot study. Cell Mol Neurobiol 2012, 32:1099-1112.
56. Souza L.C., de Gomes M.G., Goes A.T., Del Fabbro L., Filho C.B., Boeira S.P., Jesse C.R. Evidence for the involvement of the serotonergic 5-HT(1A) receptors in the antidepressant-like effect caused by hesperidin in mice. Prog Neuropsychopharmacol Biol Psychiatry 2013, 40:103-109.
57. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
58. Tadaiesky M.T., Dombrowski P.A., Figueiredo C.P., Cargnin-Ferreira E., Da Cunha C., Takahashi R.N. Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease. Neuroscience 2008, 156:830-840.
59. Tajiri N., Yasuhara T., Shingo T., Kondo A., Yuan W., Kadota T., Wang F., Baba T., Tayra J.T., Morimoto T., Jing M., Kikuchi Y., Kuramoto S., Agari T., Miyoshi Y., Fujino H., Obata F., Takeda I., Furuta T., Date I. Exercise exerts neuroprotective effects on Parkinson's disease model of rats. Brain Res 2010, 1310:200-207.
60. Tuon T., Valvassori S.S., Lopes-Borges J., Luciano T., Trom C.B., Silva L.A., Quevedo J., Souza C.T., Lira F.S., Pinho R.A. Physical training exerts neuroprotective effects in the regulation of neurochemical Parkinson's disease. Neuroscience 2012, 227:305-312.
61. Wendel A. Glutathione peroxidase. Methods Enzymol 1981, 177:325-333.
62. Wibom R., Hultman E., Johansson M., Matherei K., Constantin-Teodosiu D., Schantz P.G. Adaptation of mitochondrial ATP production in human skeletal muscle to endurance training and detraining. J Appl Physiol 1992, 73:2004-2010.
63. Zhang X., Egeland M., Svenningsson P. Antidepressant-like properties of sarizotan in experimental Parkinsonism. Psychopharmacology 2011, 218:621-634.
64. Zhao C., Ling Z., Newman M.B., Bhatia A., Carvey P.M. TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 2007, 26:36-46.